Deal Roundup: Blackstone said to near $2.17bn Alinamin Pharma sale, Aurora buys First Legal

Blackstone is reportedly closing in on a $2.17bn sale of Alinamin Pharmaceutical to MBK Partners. The firm bought the Japanese drugmaker four years ago. Reuters reported the sale progress, citing an unnamed person it said had direct knowledge of the matter who said the deal was expected to be signed soon. Alinamin was previously known …